BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38660847)

  • 1. [A Real-World Single-Center Study of Adult Hodgkin's Lymphoma].
    Wang LL; Tian L; Dong F; Yang P; Wan W; Li QH; Ma L; Gao JJ; Wang JJ; Zhao W; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):428-433. PubMed ID: 38660847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characteristics and analysis of prognostic factors of 222 patients diagnosed with Hodgkin's lymphoma].
    Hu YF; Huang YH; Luo W; Chen MX; Zhang J; Gou F
    Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3792-3796. PubMed ID: 31874516
    [No Abstract]   [Full Text] [Related]  

  • 3. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prognostic significance of peripheral lymphocyte/monocyte ratio and PET-2 evaluation in adult Hodgkin's lymphoma].
    Jia T; Zhu HY; Wang L; Liang JH; Cao L; Xia Y; Wu JZ; Wu W; Fan L; Li JY; Xu W
    Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):372-377. PubMed ID: 31207700
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of Clinical Characteristics and Prognostic Factors of 223 Newly Diagnosed Hodgkin's Lymphoma Patients].
    Liu S; Ma J; Yue YF; Li Q; Yang HL; Yu Y; Wang XF; Zhao ZG; Zhang YZ; Wang YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1296-300. PubMed ID: 26524026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A analysis of the outcome and prognostic factors in 415 patients with Hodgkin lymphoma].
    Tao Y; Kang S; Zhou L; Shi Y; Li Y; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):466-71. PubMed ID: 26463153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
    Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
    [No Abstract]   [Full Text] [Related]  

  • 10. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis analysis of primary breast diffuse large B cell lymphoma].
    Zhu YH; Meng WJ; He LH; Jia YS; Tong ZS
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):235-240. PubMed ID: 30917462
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of clinical characteristics and prognosis of patients with peripheral T-cell lymphoma.
    Liang X; Guo L; Hu X; Li S; Wen S
    Medicine (Baltimore); 2021 Apr; 100(13):e25194. PubMed ID: 33787601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis for clinicopathological features, therapy and prognosis of 30 elderly patients with non-Hodgkin's lymphoma].
    Wang HT; Yang B; Cai LL; Ran HH; Zhang WY; Zhu HL; Yang Y; Li SX; Fan H; Chi XH; Yu RL; Zhang F; Li BL; Lin J; Zhai B; Yao SQ; Lu XC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1464-70. PubMed ID: 24370030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical Characteristics of 219 Patients with Primary Gastrointestinal Non-Hodgkin's Lymphoma].
    Li YY; Hu DZ; Wang YF; Zhao ZG; Cao Z; Zhang YZ; Zhang HL; Tian C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):849-854. PubMed ID: 32552946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.
    Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Karkantaris C; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Pizzolo G; Pangalis GA
    Haematologica; 2002 Jul; 87(7):701-8; discussion 708. PubMed ID: 12091120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapy.
    Nakajima Y; Tomita N; Watanabe R; Ishiyama Y; Yamamoto E; Ishibashi D; Itabashi M; Koyama S; Takahashi H; Numata A; Takasaki H; Kawasaki R; Kuwabara H; Tanaka M; Hashimoto C; Fujimaki K; Sakai R; Motomura S; Ishigatsubo Y
    Med Oncol; 2014 Sep; 31(9):185. PubMed ID: 25142947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and prognostic factors in Chinese patients with Hodgkin's lymphoma.
    Zhu YJ; Sun YL; Xia Y; Jiang WQ; Huang JJ; Huang HQ; Lin TY; Guan ZZ; Li ZM
    Med Oncol; 2012 Jun; 29(2):1127-33. PubMed ID: 21390515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the initial management of Hodgkin's Lymphoma.
    Marri PR; Ansell SM
    Transfus Apher Sci; 2013 Aug; 49(1):12-8. PubMed ID: 23769695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
    Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
    J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
    Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.